GlassScriptPhysician profile
Ashley N August
NPI 1770642183
$2,623.45
in general payments reported to CMS, 2019-2025
28 companies · $603 in 2025
The $603 reported for 2025 was more than what 83% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.12 · 2022: $612 · 2023: $822 · 2024: $524 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.10 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $459.72 | 2021-2025 | |
| Astellas Pharma US INC | $360.73 | 2022-2025 | Veozah, Vesicare, Myrbetriq |
| Exeltis, USA INC. | $202.63 | 2022-2025 | Slynd |
| Abbvie INC. | $187.18 | 2021-2024 | |
| Evofem Biosciences, INC. | $179.58 | 2021-2024 | Phexxi |
| Sumitomo Pharma America, INC. | $151.71 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $125.12 | 2022 | |
| Sage Therapeutics, LLC | $107.09 | 2022-2024 | |
| Myriad Women'S Health, INC. | $97.74 | 2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $89.19 | 2023 | |
| Pfizer INC. | $79.82 | 2022-2025 | |
| Millicent US INC | $74.48 | 2024 | Intrarosa, Femring |
| Daiichi Sankyo INC. | $59.62 | 2022-2023 | Injectafer |
| Organon LLC | $51.99 | 2024-2025 | Nexplanon |
| Davol INC. | $42.99 | 2025 | Arista |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $39.54 | 2022 | |
| Amgen INC. | $37.55 | 2022-2025 | Evenity |
| Avion Pharmaceuticals | $36.28 | 2023 | Balcoltra |
| Therapeuticsmd, INC. | $32.73 | 2022 | |
| Scynexis, INC. | $32.48 | 2022 | |
| Merck Sharp & Dohme LLC | $30.89 | 2024 | Gardasil 9, Gardasil |
| Exact Sciences Corporation | $26.23 | 2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $23.14 | 2025 | Thinprep 2000 Processor, Aptima |
| Coopersurgical, INC. | $21.77 | 2025 | Paragard T 380a |
| Aspira Women'S Health INC | $20.94 | 2022 | |
| Convatec INC. | $19.60 | 2025 | |
| Mylan Pharmaceuticals INC. | $17.90 | 2022 | |
| Shield Therapeutics INC | $14.81 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley August listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.